An update on Targeting Gut Microbiota(GM) for  Avoidance of Metabolic dysfunction associated steatohepatitis  propagation to Hepatocellular Carcinoma-A  Narrative Review.

Dr. Kulvinder Kochar Kaur^1*, Dr Gautam Nand Allahbadia ², Dr Mandeep Singh ³

1. Scientific Director cum Owner  Dr Kulvinder  Kaur Centre For Human Reproduction 721,G.T.B. Nagar, Jalandhar-144001, Punjab, India.

2.  M.D.(Obstt&Gynae),D.N.B, Scientific Director, Ex-Rotunda-A Centre for Human Reproduction, 672,Kalpak Garden, Perry Cross Road, Near Otter’s Club, Bandra(W)-400040, Mumbai, India.

3. M.D.DM.(Std)(Neurology), Consultant Neurologist,  Swami Satyanand Hospital, Jalandhar-144001, Punjab, India

*Correspondence to: Dr Kulvinder Kochar Kaur M.D (Obstt & Gynae specialist reproductive endocrinology & Infertility specialist).  Scientific Director cum Owner  Dr Kulvinder  Kaur Centre For Human Reproduction 721,G.T.B. Nagar, Jalandhar-144001, Punjab, India,

Copyright

© 2025 Dr Kulvinder Kochar Kaur. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: 17 January 2025

Published: 03 February 2025

DOI: https://doi.org/10.5281/zenodo.14807645

Abstract

Metabolic dysfunction associated  steatotic  liver disease(namely MAFLD) as well as propagation to   Hepatocellular carcinoma(HCC),  displayed unique molecular along  with immune  traits .Such properties get impacted  by a  plethora of factors inclusive of gut   microbiome that crosstalk with liver via   the ‘gut - liver axis’. The bidirectional association amongst gut in addition to its  microbiota along with liver possesses a  critical part  in guiding different liver diseases, with microbial metabolites   as well as immune reactions possessing a  central part  in such  events .Here we have attempted to update our earlier  work  with regards to part of gut microbiota(GM)  aiding in generation of Metabolic dysfunction associated steatohepatitis( MASH) as well as propagation to HCC, highlighting   the recent advancements  in diagnostic  in addition to therapeutic interventions with regards to  use  of  faecal microbiota  transplantation(FMT), probiotics, prebiotics, synbiotics, antibiotics, along with  immunotherapy using a plethora of clinical as well as preclinical studies in avoidance of MASH along with propagation to  HCC as well as detailed mechanistic modes of such treatments exhaustively   inclusive of methodologiesof administration of  FMT as well as  their approval by Food  and Drug   Administration(FDA),  just for treatment of recurrent Clostridium  difficile   infection(CDI) ,with  future opportunities for therapeutic interventions in a  plethora of diseases  like obesity, irritable  bowel syndrome (IBS), Parkinson’s  disease,  metabolic syndrome  (MetS)  type 2 Diabetes mellitus(T2DM), neuropsychiatric disease (NPD) (Autism spectrum disorder (ASD) .More  research is needed to overcome the restrictions along with correlated hurdles.

Key Words; gut microbiota(GM)  ; avoidance of Metabolic dysfunction associated steatohepatitis( MASH); Hepatocellular carcinoma(HCC); immunomodulatory treatments

Introduction

The human gut    comprises of enrichment as well as variation of   microbial population in addition to bacterial variations in the colon has been determined tobe   10 11 -10 12/ml[1]. Over the past few years extensive   work has been conducted to understand the critical significanceof trillions of bacteria that are present in the gastrointestinal tract (GIT) along with dynamic interaction among the heterogenous  make-up of this large microorganism community along with  chances of getting various diseases like obesity, type 2 diabetesmellitus (T2DM) .The molecular strategies implicated are for  instance  metabolomics, lipidomics, metatranscriptomics along with metagenomic unraveled theinfluence of gut microbial population in variable organs[2]. The changes in the microbial constitution in the gut result  in generation of different diseases inclusive of  inflammatory bowel disease (IBD), irritable  bowel syndrome (IBS), Coeliac  disease,type 2 diabetesmellitus (T2DM), atopy , autoimmune diseases(for  instance    Ulcerative colitis (UC),lupus, Crohn’s disease(CD), Multiple Sclerosis (MS), steatosis in addition to variable carcinomas (oral, gastric, colorectal cancer[3,4,5 rev by us in bile acids cancer& type 1 diabetesmellitus (T1DM) ]. Gut microbiota(GM) comprises  of variable organisms inclusive of bacteria, viruses along with yeast. Firmicutes along  with Bacteroides portray the pronounced  phyla in the GM constitution[6]. Other  microbes  inclusive of  Actinobacteria, Proteobacteria, Fusobacteria as well as Verrumicrobia   are  further present . Firmicutes phylum basically comprises  of  200 separate genera for  instance Lactobacillus, Clostridium , Bacillus,Ruminococcus as well as Enterococcus .Of Firmicutes phylum Clostridium genera is the maximum predominant(95%).Bacteroidetes get constituted  by genera for  instance  Bacteroides along with Prevotella[7]. In the clinical study it  was  displayed that the existence of Ruminococcus obeum as well as the Alistepes were diminished whereas enrichment of Dorea, Lactobacillus in addition to Megasphaera were observed in Non alcoholic fatty liver disease(NAFLD) patients in contrast to healthy subjects [1,8]. In contrast to NAFLD patients, patients with non alcoholic steatohepapititis(NASH),had greater quantities of Firmicutes, however lesser    quantities of Bacteroides at  the  phylum level [9]. In the studies it  displayed that patients with cirrhosis revealed greater quantities of Enterobacteriaceae as well as Streptococcus, however lesser    quantities of Akkermansia.  In the patients with Hepatocellular carcinoma(HCC), quantities of Bacteroides along with Ruminococcus was  observed whereas diminished Bifidobacterium quantities were observed. An inverse association was  observed amongst calprotectin(cellular inflammatory marker) .Faecal microbial variation  is clear cut  in cirrhosis to early   HCC in addition to the existence of Actinobacteria phylum was greater in the early   HCC stage. Akin to that Gemmiger as well as parabacteroides was greater in early   HCC in contrast to cirrhosis .Conversely,  butyrate generating genera diminished in addition to lipopolysaccharide(LPS) generating genera enrichment occurred in contrast to healthy subjects[10,11]. Escalation of HCC incidence might takes place in view of aberrant    escalated Firmicutes : Bacteroides ratio  occurring    in NASH patients[12]. There is existence of proof that alterations in the constitution along with variation of the gut   microbiome might result  in generation as well as propagation of variable liver diseases. Metabolic impairment associated  steatotic  liver disease(namely MAFLD) earlier referred to as Non alcoholic fatty liver disease(NAFLD) portray   a variety of liver disorders which have the properties of accrual of  extra fat in the liver(≥5% hepatic   steatosis).The  origination of disease spectrum occurs with steatotic  liver disease (SLD) which portrays the early stage of  accrual of fat in the liver[13]. On propagation of disorder, it might form metabolic MASH earlier referred to as non alcoholic steatohepatitis(NASH ) that implicates liver inflammation in addition to injury, plausibly with or without fibrosis. With further advancements of MAFLD stages, MAFLD might further result  in generation of cirrhosis, liver failure as well as further liver cancer[14]. Epidemiological proof has demonstrated that NAFLD in addition to  its  more robust kind NASH has been escalatingly acknowledged to mainly aid in generation of HCC. Dysbiosis in the gut  microbiome possess the capacity of  disturbing homeostasis, aggravating liver cell  by  stimulating different kinds of immune modulated  reactions. Variable genomic factors disturb  the gut-  liver axis as well as escalate  microbial exposure to the liver[15]. There is existence of proof that microbial metabolites for  instance bile acids, trimethylamine in addition to short chain fatty acids (SCFA)etc are involved  in the initiation along with propagation of liver diseases[16].  Inappropriate microbial generation in addition to microbial products gaining entry into liver take place via portal vein which might result  in hepatic  inflammation along with resulting   in the generation of propagation of NAFLD to NASH[17]. The  GM  impacts propagation of NASH to HCC through modulating  variable factors for  instance i)gut epithelial permeabilityii)  endogenous alcohol formation iii) choline metabolism   iv) bile acids metabolism as well as liberation of proinflammatory cytokines[18,19]. Earlier  we had  reviewed different methods of treating  NAFLD/ NASH ,concentrated on organokines liberated by AT , liver  that are key organs for controlling of lipid metabolism basically organokines (adipokines;hepatokines;myokines;osteokines stellakines),role of GM in MAFLD, NASHand  HCC avoidance [20-35].

The aim of this review to   detail the significance  of GM manipulated impacts  on Metabolic dysfunction associated steatohepatitis( MASH) along with HCC. Additionally,  it  emphasizes on the major diagnostic  in addition to therapeutic significance  of GM in MASH along with HCCwith updated therapeutic measures (see (Figure1) rev in ref no-36.

Figure1

Courtesy ref no -36-Progression of liver disease from MASH to hepatocellular carcinoma via gut–liver axis dysregulation. The figure illustrates the pathological progression from MASH to HCC through disruptions in the gut–liver axis. The MASH liver exhibits alterations in the intestinal barrier and gut microbiota, leading to dysbiosis characterized by fluctuations in key bacterial populations. The dysregulated gut microbiota affects the intestinal barrier's integrity, fostering mucosal degradation and tight junction disruption. This breakdown facilitates the systemic infiltration of lipopolysaccharides (LPS) and other bacterial metabolites into the liver through the portal circulation. Increased TLR (Toll-like receptor) activation in the liver induces inflammation, progressing from simple steatosis to cirrhosis and ultimately culminating in hepatocellular carcinoma. Key changes in microbial populations include increased Firmicutes and Proteobacteria, with a decrease in Bacteroides, Erysipelotrichia, Ruminococcaceae, Rikenellaceae, and Bifidobacteriaceae. The figure also notes a decrease in bile acid (BA) deconjugation, short-chain fatty acids (SCFA), and butyrate-producing bacteria, which are critical to maintaining hepatic and intestinal health. Symbols: ↑increase, ↓decrease

Methods

Here we conducted a narrative review utilizing search engine pubmed,google scholar ;web of science ;embase;  Cochrane   review  library  utilizing  the MeSH terms  NAFLD; NASH; Metabolic impairment associated  steatotic  liver disease(namely MAFLD) ;organokines; short chain fatty acids (SCFA); MASH; choline metabolism   ; Firmicutes :Bacteroides ratio  ;Fructose; Gut  Microbiota; Insulin Resistance; faecal microbiota  transplantation(FMT), probiotics; prebiotics;  ,antibiotics; immunotherapy;obesity;T2D from last 10 yrs till date in 2024.

 
Results

We found a total of 750 articles out of which we selected  111 articles for this review. No meta-analysis was done.

Immunomodulatory  part of Gut Microbiota(GM)  in MAFLD to MASH Propagation

A plethora of clinical as well as preclinical studies have demonstrated  that aberrant expression of GM in addition to its metabolites are intricately  correlated with liver diseases   for  instance  MAFLD along with MASH, cirrhosis as well as HCC[37,38]. The variations in the GM possess the capacity of promoting the generation of free  fatty acids(FFA) in the  intestine in addition to escalate  permeability of  FFA   over  intestinal  region which might result  in generation of NAFLD[39]. A plethora of studies pointed that   high  fat diet(HFD), had the capacity of escalating  the quantities  of alcohol generating  for  instance  Escherichia  genus members of the Proteobacteria phylum in the gut which might form acetate as well as acetaldehyde through the oxidation of ethanol in addition to promote the generation of fatty acids along with aid in NAFLD formation[40]. Recent studies pointed that GM  gets   changed in view of genetic susceptibility in addition to  incorrect diet which might influence hepatic carbohydrate as well as  lipid metabolism as well as impact the   actions of antiinflammatory along with proinflammatory compounds in the liver,  that might result  in generation of NAFLD propagation to NASH[38]. The ingestion of obesity stimulating diet for  instance HFD might disturb gram negative bacteria   whose   existence is there in the intestinal tract as well as  escalate the quantities  of  LPS which might  work in the form of critical controller in generating  inflammatory reactions in the liver tissue in addition to generating liver damage through TLR4 signaling along with result  in generation of NAFLD as well as its  propagation [39]. Additionally, HFD possesses  the capacity of after modulation the enzymes generated by gutmicrobiome,it might   work in the form of  a catalyst for the transformation of choline to toxic   metabolites referred to as dimethylamine along with   trimethylamine. Such metabolites might be  transformed into trimethylamine-N-oxide (TMAO), in the liver, that   generates inflammation in the hepatocytes as well as propagation of NAFLD to NASH[41]. The clinical studies pointed that bacterial  overgrowth in the   small intestine in view of HFD in addition to  genetic factors in case of NAFLD might escalate the risk of   NASH generation[42]. Small  intestinal bacterial  overgrowth(SIBO) pronouncedly impacted  propagation to NASH in case of NAFLD subjects.Wiggs etal. [44], performed a   contrasting study for the asssessment of  existence of SIBO in NASH subjects in addition to healthy controls[43]. They revealed that  50% of NASH subjects displayed SIBO while SIBO was restricted to 22% in healthy controls.  Asssessment of  average quantities of tumor necrosis factor alpha(TNF-α) got in NASH subjects along with healthy controls which was observed  as  14.2  as well as  7.5pg/ml respectively. Quantification of the intestinal bacteria conducted by  utilization of glucose hydrogen breath test in addition to  quantitative aspirate culture obtained from jejunum(the elimination along with culture of intestinal  fluid) with results pointing that low grade  SIBO about≥103 CFU/ml in NASH subjects in contrast to controls. Such outcomes demonstrated that NASH subjects possessed   the  maximum prevalence of SIBO[44].Shanab etal. [46], revealed that  an escalated quantities of SIBO in NASH subjects escalates the  liberation of Interleukin 8(IL-8) in addition to escalates  the expression of TLR4  which promotes  the generation along with propagation to NASH [45]. The dysequilibrium amongstTLR further aids in propagation of NAFLD to NASH. Aberrant bacterial deoxy ribonucleic acid(DNA), LPS as well as other   endogenous substances     possess the capacity of activating the  innate immune system through TLR4 in addition to TLR9 which promotes  the generation of Kupffer cells along with IL-1β . IL-1β supports the accrual of lipids as well as possesses  the capacity of escalating cell demise of hepatocytes with subsequent inflammation in addition to steatosis [46].  Furthermore microbial, pathogen–associated molecular patterns(PAMP) possess the capacity of activating the variable nucleotide-binding domain, leucine-rich-repeat containing family, pyrin domain-containing (NLRP) inflammasomes for  instance  NLRP1, NLRP3, NLRC4(IPAF),AIM2 as well as NLRP6 have the capability of  promoting the propagation of NAFLD in addition to  development of steatosis [47]. The  accumulating proof has demonstrated that TLR4 in addition to microbial obtained LPS are the crucial factors implicated in propagation of cirrhosis[48]. Gut dysbiosis might result  in systemic  inflammation along with immunoinsufficiency  by leading  to dysfunctional   working of the immune cells for  instance Tcells,B cells as well as macrophages etc in addition to result  in generation of cirrhosis associated immune  dysfunction(CAID). CAID has the capability of facilitating the translocation of bacterial products into the blood circulating cells along with   magnitude of    the inflammation[49].  Additionally, gut dysbiosis has the capability of disturbing bacterial  flora as well as promoting the LPS/ TLR4 modulated  signaling. Gut dysbiosis further might be involved in originating cirrhosis to cancer propagation through escalated  liberation of chemokines in addition to chemotaxis of Kupffer cells, that stimulate the profibrinogenic cytokines for  instance transforming growth factorβ 1(  TGF-β1) [47]. Various inflammatory pathways are responsible  for the cirrhosis to HCC propagation stimulated by interactions amongst intestinal  bacteria, immune system along with liver. The inflammatory event basically incorporates crosstalk amongst macrophages,Kupffer cells along with PAMP in the liver cells. Macrophages,Kupffer cells along with PAMP possess the capacity of among eliciting nuclear factor-κappa light chain   enhancer of activated B cells(NFκB) pathways via  binding nucleotide-binding oligomerization domain (NOD) –like receptors in addition to TLRs  specifically  TLR4 along with TLR9[51]. GM modulated TLR4 signaling   pathway takes place as the proinflammatory reactions in the liver as well as   facilitates HCC production[52]. The inflammatory chain reactions might  evoke   escalated liberation in addition to inflammation in liver which in  turn result  in dysbiosis of microbiota .Such Kupffer cells modulated liberation of proinflammatory cytokines for  instance TNF-α, IL-8 , along with IL-1β. Escalated cytokines might  evoke lipids  accrual as well as hepatocytes apoptosis in addition to leading to steatosis along with inflammation. escalated proinflammatory cytokines in view of aberrant GM controlling were found in practically  all the NAFLD in addition to NASH subjects that facilitates the generation along with propagation of NASH viaTLR stimulated pathways[53]. Thereby GM modulated cytokines possess a crucial part in the origination as well as    propagation of NAFLD to NASH to HCC[54]. Dysbiosis stimulated by cirrhosis associated with escalated intestinal permeability might stimulate liberation of PAMPs in addition to metabolites modulated by  gut  microbiome, which result  in escalated inflammation, injury along with fat  generation in the liver[55]. As per scientific researchers PAMPs start liberation of cytokines, chemokines for  instance IL-8 , IL-17 along with IL-1β via  TLRs activation precipitating immune cell existence in the liver [56]. Persistent generation  of cytokines might result  in DNA injury along with Oxidative   stress( OS)  , therefore  leading to starting as well as  advancement of HCC[57].  Additionally, generation of microbial metabolites for  instance bile acids(BA), trimethylamine, short chain fatty acids (SCFA), PAMPs, lipoteichoic acid (LTA), in addition to branch chain amino acids have been acknowledged to activate  hepatic stellate cells(HSCs) through the senescence- associated secretory phenotype(SASP) ,facilitating proliferation of hepatocytes as well as proneness to HCC[58].  Clinical  along with preclinical studies have illustrated that BA  metabolism   further possesses a  significant   part in propagation of NASH to HCC[59].  Escalated quantities of BA in the liver possess the capacity of stimulating  inflammation , hepatocytes DNA injury in addition to apoptosis; therefore tumorigenesis  would  take place in the liver [60]. Moreover, dysbiosis in NASH would   escalate the enrichment of gram positive microorganisms in the microflora, therefore stimulating HCC via   escalated generation of secondary bile acids inclusive of  deoxycholic acid (DCA) that limits  the activation of   liver sinusoidal endothelial cells (LSECs) as well as promotes the repression  of C-X-C motif  chemokine   ligand6( CXCL6),  enrollment of natural killer Tcells(NKcells), along with develop tumorigenesis[61]. Furthermore ,secondary bile acids directly   stimulate HCC generation NASH by stimulating mammalian target of rapamycin (mTOR)  [62].  Guerra-Ruiz   etal. [61],  illustrated that serum quantities of LPS binding protein (LBP)  were  significantly escalated   in NASH individuals   in contrast to healthy patients with simple steatosis .The  escalated serum quantities of LBP were associated with  aberrant expression of TNF-α in the liver tissue.The  escalated quantities of TNF-α possess a critical part in generating HCC[63]. Obesity portrays  another risk factor   which impacts the alterations   in the constitution  of microbiota as well as its metabolites for  instance LPS in addition to PAMP[64]. The  damaged hepatocytes possess the capacity of generating damage –associated molecular patterns(DAMP) that stimulate  the inflammatory  molecules through TLR in addition to activation of immune  cells transition from NAFLD -NASH- HCC[65]. There is  presence of proof that gut   microbiome possess the capacity of affecting  antitumor reactions that might yield an  innovative   approach for improvement  of efficacy  of cancer   immunotherapy[66].   Accumulating proof has demonstrated that, aberrant characterization of GM might evoke immunorepression  by  induction of M2(pro tumor)- like tumor associated macrophages(TAM) . Intestinal    dysbacteriosis correlated with IL-25 stimulated activation of  M2 macrophages possess the capacity of accelerating HCC  propagation  by liberation of C-X-C motif  chemokine   ligand 10( CXCL 10), along with accelerate epithelial –mesenchymal transition (EMT) [67]. Variable studies illustrated that GM possessed the capacity of generating  oncogenesis  in addition to propagation  in  myeloid derived suppressor cells (MDSC) based way [68].  Aberrant GM modulated dysbiosis further had  the capacity of disrupting homeostasis, sequentially facilitating immune modulated hepatocytes damage which further  stimulates   HCC propagation.Metabolomic in addition to metagenomic studies associated with GM illustrated that GM are capable of leading to  Tcell modulated immunrepression   through escalating the quantities  of regulatory Tcells (Treg) as well as the reduction of quantities of CD8+ T cells inclusive of cytotoxic Tcells [69]. Furthermore, Looetal. [19], illustrated that GM possessed the capacity of generating prostaglandinE2 in addition to cyclooxygenase2(COX2) enzymes that hamper  antitumor reactions  via prostaglandinE2 receptor4(EP4), therefore facilitating HCC propagation[19]. Expression of various proteins  for  instance CD68(cluster of differentiation68) is  believed tobe a marker   macrophages, as well as TLR(TLR2, TLR4, TLR 5, as well as TLR9) possesses a negative part  in activation of the innate immune system. Variable studies illustrated that CD68 is a TAM along with result  in the generation along with propagation of NAFLD in addition to NASH to HCC propagation[37]. It further pointed that  a leaky   gut might lead to overgeneration of GM obtained metabolites affecting the hepatic immune system as well as escalating the HCC  risk[70]. ( Figure2).

Figure2

Courtesy ref no -36-Potential mechanisms for gut microbiota-associated immune modulation in MASH–HCC progression. This figure illustrates the complex immune interactions and cellular transformations involved in the progression from MASH to HCC. Key features include the early infiltration of neutrophils leading to inflammation, liver injury, and fibrosis, and the role of B2 cells and CD8 + T cells in modulating the immune response. Activation of CD8 + T cells contributes to further liver injury and steatosis, while the presence of myeloid-derived suppressor cells (MDSC) indicates an immune suppressive state facilitating cancer progression. The diagram also highlights the activation of macrophages through toll-like receptors (TLR4 and TLR9) leading to an increase in inflammatory cytokines (IL-6, TNF-α) and COX-2, which are important in the development of HCC. Additionally, the impact of various cytokines such as TNF-α, IFN-γ, IL-17, IL-4, and IL-13 on the hepatic environment, promoting steatosis, fibrosis, and liver injury, is depicted. Abbreviations and symbols: B2 cells: a type of B cell involved in immune response; CD8 + T cells: cytotoxic T cells which are a part of the immune system that kills cancer cells, virus-infected cells, and other damaged cells; COX-2: cyclooxygenase-2, an enzyme that plays a crucial role in inflammation; HCC: hepatocellular carcinoma; IFN-γ: interferon gamma, a cytokine critical for innate and adaptive immunity; IL-4: interleukin 4, a cytokine involved in the regulation of immune responses; IL-6: interleukin 6, a cytokine involved in inflammation and maturation of B cells; IL-13: interleukin 13, involved in inflammatory responses; IL-17: interleukin 17, a pro-inflammatory cytokine; iNK cells: invariant natural killer T cells, a component of the immune system that recognizes lipid antigens; MAIT cells: mucosal-associated invariant T cells, involved in the mucosal immunity; MDSC: myeloid-derived suppressor cells, regulate immune responses in cancer; NASH: non-alcoholic steatohepatitis

Immunotherapeutic Importance   of Manipulating GM in MASH along with HCC

NASH stimulated dysbiosis in GM results  in escalated intestinal permeability, therefore escalating  exposure  to bacterial metabolites, in the liver  leading to robust inflammation aiding in HCC[71].  Manipulating GM modulated BA metabolism, actions of TLR, controlling Farsenoid X receptor[FXR] Takeda G protein coupled (GPC) bile acid receptor 5(TGR5) activation, choline metabolism, as well as targeting proinflammatory cytokines has been believed tobe an innovative   approach  for the   therapy of NASH along with NASH linked HCC[19]. Targeting GM against NASH as well as HCC apparently is a substantially promising  strategy,  in addition to concurrently possesses no inimical sequelae with considerable safety profile inclusive of faecal microbiota  transplantation(FMT), probiotics, prebiotics, synbiotics, antibiotics, along with  immunotherapy[12]. The pronounced mechanistic modes by which therapeutically targeted treatment’s work are i) regulating  T   helper cells 17(Th17) cells proliferation that escalate   the liberation of interleukin (IL)-17, ii)decreasing  quantities  of metastasis  via diminishing overexpression of vascular endothelial growth  factors(VEGF), iii)restricting angiogenesis ,lymphangiogenesis in addition to   inflammation [72].iv) Furthermore, changes in the controlling of GM stimulates the generation of SCFA as well as  limit the propagation of NASH to HCC. Manipulating GM constitution might result  in upregulation of propionate  which aid patients  in getting over  HCC via cyclic 3’5’ adenosine mono phosphate(cAMP) quantities based pathway in addition to stimulation of G protein coupled receptor43 (GPR43) [69]. V)Additionally, controlling of GM might have  anti HCC  actions  by  escalating the quantities  of hepatic CXCL6  + NKTcells along with escalating the quantities  of interferon α ( IFN). Concurrently CXCR6+ NKTcells accrual got regulated  via  the expression   of CXCL6  in LSECs that got communicated with  microbiome  stimulated  by primary to secondary BA transformation[74]. Figure3  summarizes variable approaches for  targeting gut microbiota faecal microbiota  transplantation(FMT), probiotics, prebiotics, synbiotics,antibiotics[rev in ref 75].

Figure3

Courtesy ref no -75-Different ways to manipulate gut microbiota.

i)Basically probiotics  get used  for restoration of microbial dysequilibrium[62]. Clinical   use  of probiotic   bacteria illustrated decreasing rates of propagation of NASH as well as decreasing HCC cells spreading  by reduction of   activation of  inflammation modulated by TLR’s. PAMP’s aid in  generating  NASH as well as HCC by activation of  inflammatory  reactions via TLR’s. Utilization of probiotic   bacteria have illustrated that they are capable of ameliorating  liver metastasis by decreasing escalated inflammatory  reactions stimulated  by TLR’s[76].In  experimental    liver cirrhosis in rats  which received treatment with Lactiplantibacillus plantarius illustrated decreased TLR4   expression in addition to scanty liver injury. Furthermore, by sterilization   of  gut along with dysactivation of TLR4 receptor significantly curtailed propagation of HCC by 80% pointed  their plausibility in the form of avoidance strategies HCC[77]. Li etal. validated  in 2016   , that  a combination   of   probiotics possessed   the capacity of decreasing liver  fat  proinflammatory cytokine for  instance   interleukin (IL)-17 in case of mouse models .It further pointed  that probiotics had the capacity of decreasing liver fat  in addition to quantities  of aspartate  amino transferase (AST) in NASH   individuals[78] [NCT00870012,NCT01791959]. The probiotics stimulates the growth of microbial constitution towards advantageous bacteria inclusive of Prevotella as well as Oscillibacter. Prevotella as well as Oscillibacter evoke antiinflammatory metabolites which subsequently decrease Th17 polarization along with escalating the differentiation of regulatory Tcells (Treg) / type 1 regulatory T cells( Tr1) in the gut  in addition to generation of antiinflammatory reactions in the  cancer cells .Additionally,  probiotics are capable of  regulating   aberrant growth of  segmented   filamentous  bacteria(SFB) which portray bacteria that possess the capacity of liberation of quantities  of Th17 in the body. Thereby probiotics delivery  diminished quantities  of SFB by a  considerable magnitude leading to significant decrease in generation of proinflammatory cytokines for  instance   IL-17. The IL-17A  produced  by Th17 might promote angiogenesis  therefore diminished Th17 along with IL-17 quantities might decrease propagation of HCC . Clinical  in addition to preclinical studies have illustrated that probiotics   were  efficacious against NASH as well as HCC[79].  Moreover ,Helicobacter  spp   were observed encompassing NASH  along with its translocation might be of use in evoking HCC . With that  idea, intestinal microbiota profiles might pronouncedly display advantageous actions in HCC patients that got immune checkpoint  receptors(ICRs) which pointed that gut microbiota targeted immunotherapy might  be advantageous in the treatment of liver cancer [80]. In a double blind, randomized, placebo   controlled  trial probiotics in cases   of  Child Pugh A B cirrhosis got performed   for the asssessment of  anticipative part of gut   microbiome in the generation of HCC.As per this specific study, asssessment of  part of probiotics towards the existence of endotoxins(LPS) as well as cytokines (TNF-α along with IL-6 )in the tumor microenvironment( TME ) in addition to further  asssessed the expression of TLR4 in the mononuclear cells [NCT038513928] [81].

ii)Prebiotics are  a nonviable food component which imparts health benefits on the host associated with microbiota modulation which might be a fiber, that basically  are  non absorbant  oligosaccharide  substances  which aggravate   bacterial growth in addition to sustenance of GM decreasing NASH  along with NASH correlated  HCC[82]. Dietary polyphenols portray significant  prebiotics whose  utilization is  done  currently inclusive of flavonoids which include  lignins as well as phenolic acid that  have been found in tea,   vegetables,fruits,legumes,nuts,red  wines. One of  maximum significant  prebiotic polyphenols  is egallic acid which portrays an antioxidant acid which possesses  anticancer characteristics.  Metabolism of egallic acid take place  by microflora whose existence is in the colon generating urolithins whose enrichment is in nuts along with berries[83].  Urolithins possess the capacity of   repression   of COX2 correlated inflammation in the liver cells[84]. One  more  polyphenol for  instance resveratrol,  that is existence in the grapes are capable of  diminishing   or avoidance of NASH[85]  in addition to HCC propagation by  breakdown of invasion of metastasis as well as tumor  cell migration in case of liver cancer[86] .Resveratrol works apart from    in the form of an immunomodulatory substance by stimulating immune cells which have placement in the TME,or sensitization of tumor cells towards cytotoxic  signaling of immune cells[87] .Querceetin represents one  more   flavonoid which functions in the form of  a   repressor of nuclear factor-κappa light chain  enhancer of activated B cells(NFκB) in the hepatocytes [88]. A   prospective cohort study illustrated that escalating the ingestion of  tree nuts for  instance almonds, hazelnuts, pistachios,   macadamias, cashews along with pecans had an association with diminished NASH  along with HCC[89].  The combination  of  pectins  in addition to  fructoligosacchharides(FOS), raspberry  polyphenols over microbial fermentation as well as inflammation manipulation along with asssessment of lipids in the liver was  which pointed  that FOS in addition to    pectins resulted  in improvement   of raspberry   extract  against NASH as well as HCC[90]. Furthermore, a study on   hepatocytes illustrated that polyphenols extracted from raspberries further regulated     immunometabolic  signals correlated with obesity generation[91]. Prebiotics supplementation further aid in  activation of 5’ AMP-activated protein kinase(AMPK) [92]. Astralagus, polysaccharides,grifolan,lentinan as well as krestin(PSK) illustrate anticancer characteristics by controlling actions of immune system in addition to stimulating direct actions against cancer cells [104]. Clinical studies illustrated that   omega-3 fatty acids along with eicosapentaenoic acid (EPA),had activity against HCC [NCT04682665].Certain  clinical trials further displayed efficacy of prebiotics, along with synbiotics against NASH [NCT02530138, NCT01791959, NCT03184376, NCT03897218].

iii) Additionally, antibiotics utilization might   be  done to  diminish or    eliminate   changed gut microbial quantities; that aid in   limiting inflammatory signals from leaky   guts. Various preclinical studies corroborate that separate antibiotics for  instance vancomycin, metronidazole, neomycin in addition to    ampicillin significantly diminished HCC proliferation[94]. Antibiotic cocktails[(ABX) inclusive of vancomycin, neomycin as well as primaxin generated anti- HCC     actions .Such antibiotics possess the capacity of escalating  the quantities  of  hepatic CXCL6  + NKT  cells in addition to the quantities  of IFNγ along with hampering growth of cancer cells[95]. A  phase 2    interventional study asssessment of safety as well as effectiveness of solithromycin against NASH without cirrhosis had been done[NCT02510599]. A randomized interventional clinical trial illustrated the actions of rifaxim on LPS along with associated cytokines in case of NAFLD in addition to    NASH [NCT02009592], continuation of antibiotics from  β-lactams, tetracycines, fluoroquinolones, sulfonamides, aminoglycosides influence    human   gut flora. They possess the capacity of modifications in the diversity of GM along with constitution which result  in metabolic  changes in  body metabolism of SCFA which aid in start along with propagation of NAFLD[106]. Decontrolled   metabolism  in the body specifically in the metabolism of SCFA might result  in obesity, type2 diabetes mellitus( T2DM), as well as metabolic  syndrome (MetS). Additionally, studies pointed that persistent antibiotics utilization might result  in elimination of gut bacterial diversity along with escalate the predisposition  to infection  [96]. Persistent antibiotics utilization might escalate the quantities  of antibiotics   resistant genes  in the microbiome. These    resistant genes pools  might start antibiotics resistance[97]. In such a setting  the   main botheration  is   promoting the growth of advantageous microflora, in the meantime   diminishing the percentage of microbiota involved in dysbiosis generation for facilitating individuals health. Thereby the generation of innovative antibiotics might be  individualized for a  person dependent on  intestinal along with biochemical personality. Selective antibiotics utilization  would diminish  the negative influence of antibiotics  on  human health in view of alterations  in gut   microbiome[98].

iv)Faecal microbiota  transplantation(FMT), represents a medical  methodology which has been responsible   for switching  of a stool sample from a  healthy  individual   to an   individual who   is diseased [99]. The healthy stool  samples constitution is of trillions of advantageous bacteria in the lower intestine , that possess the capacity of mitigating  disease . Different studies have displayed that FMT possesses the capacity of  restoration of healthy bacteria in the lower intestine that would further aid in   stopping Clostridium  difficile  (C. difficile) from the  intestinal  region[100,101]. The manner detailed earlier , healthy   intestinal tract  has  considerable quantities  of  healthy bacteria, nevertheless, in certain situations for  instance, antibiotics utilization might limit the growth of the bacteria believed to  be  good, which might be   facilitating growth of unhealthy bacteria in the colon. There  is predilection for the FMT utilization for the treatment of Clostridium  difficile   infection(CDI) in addition to cases  of IBD[102,103]. Dependent on FMT clinical trials, FMT utilization has further been advocated   for  irritable  bowel syndrome (IBS), Parkinson’s  disease,  metabolic syndrome  (MetS)  type 2 Diabetes mellitus(T2DM), neuropsychiatric disease (NPD) (Autism spectrum disorder (ASD) [103,104,rev by usin ref 106]. Various methodologies might be used  for  instance colonoscopy, enema, nasogastric(NG) tube, oral capsules(VOW-ST,SER-109) [107,108].Presently  as per recommendations  by Food  and Drug   Administration(FDA), FMT is just recommended for recurrent CDI which does not display response   to   the   canonical antibiotics treatment.Two separate FMT treatments  received recommendations by  FDA- FDA REBY OTA(faecal microbiota-live -JSLM0 as well as  VOWST[109].  Different studies have displayed that FMT is efficacious in  80-90% in avoidance   of recurrent CDI subsequent   to  antibiotics treatment . However there are different long as well as  short term inimical sequelae correlated with FMT[110]. Therefore intense  screening of donor in addition to asssessment is warranted with regards to guaranteeing practically negligible inimical sequelae. See Figure4 for FMT details and  mechanistic modes .

Figure4

Courtesy ref no -75-Non-alcoholic-fatty-liver-disease (NAFLD)-related dysbiosis and increased intestinal permeability and the utility of faecal microbiota transplantation (FMT). The increase in intestinal permeability enables bacteria and their metabolites to reach the liver through the portal system. In FMT, a stool sample is taken from a healthy donor. After processing, it will be administered to the receptor subject with NAFLD. The FMT can be performed in different ways, either orally or by endoscopy or enemas. FMT is intended to reverse existing dysbiosis and restore the intestinal barrier, and consequently improve the severity of the disease.

Restrictions along with Hurdles

Although, we have  exhaustively  updated    part of gut microbiota(GM) in the production of NASH along with propagation its  to   of HCC ,remarkable restrictions along with hurdles still need to  be  evaluated.

a) of the maximum detailed studies-most are   preclinical- which   implicate animal models or in vitro studies- Despite yielding understanding ,they do not possess the capacity of  reproducibility of the complicated crosstalk along with environment factors  affecting GM in addition to propagation of liver diseases . Thereby -translation of such observations    in clinical scenario  is  problematic in view of human studies have revealed separate outcomes which  are more complicated .

b) The gut   microbiome is considerably  complicated with extensive microbial spp characterization is still to be performed. Such complicated nature ensures botherations implicated in estimation of etiological association amongst  microbial alterations   as well as disease status .Still there is no insight on the working of plethora of microbial spp amongst the microbiome in addition to their association with host  metabolism along with immunity.

c) Existence of significant variations have been observed in GM constitution amongst separate populations in view of dietary, genetics, lifestyle along with antibiotics utilization. Such variations might be influencing replication in addition to application of observations  over separate demographic as well as   geographical placement  grps.

d) Present technologies  for    evaluation    of gut   microbiome for  instance 16S rRNA sequencing  as well as metagenomic sequencing possess restrictions in resolution in addition to precision,   therefore might not pick up the entire spectrum of microbial variations or the working capacity of the microbiome. Furthermore , such methodologies   are   prone for   contamination as well as   involve remarkable   technical hurdles which might influence quality of asssessment in addition to  interpreting outcomes  obtained.

e) Although manipulation of GM apparently  is  attractive, therapeutic innovative   approach, However, generating efficacious GM  dependent therapies is  problematic. Problems are inclusive of  guaranteeing stability in addition to probiotics survival, ii)unanticipated prebiotics actions on   the present gut microflora along with   iii) probability of inimical sequelae  from spectrum of antibiotics

f) The controlling with regards to microbiota targeted therapies   is not completely generated that might interfere with fashioning  of clinical trials, approval in addition to  marketing accessibility. Furthermore safety  issues have to be taken into  account, specifically with regards to changes in long term influence on  the gut   microbiome on immune working as well as proneness to diseases.

g) The crosstalk amongst GM manipulated treatments  in addition to   existent treatments for  NASH along with HCC continue to  be uncharted, specifically in lesser resource setting . Such crosstalks might influence effectiveness as well as safety profiles of  therapies.

h)The expenditure incurred  in generating gut microbiota targeted treatments  in addition to   methodological  needs might restrict  their accessibility specifically in lesser resource settings  which have considerable  NASH along with HCC prevalence.

Conclusions 

Thereby  GM which is not   healthy along with its metabolites   result  in development of  inappropriate   immune signaling in the liver , which result  in start as well as propagation of variable liver diseases for  instance MAFLD ,MASH, in addition to specifically propagation to HCC  Probiotics, prebiotics, synbiotics, might be  examples of  safe, cheap treatment approaches of  use against  such  diseases. Nevertheless, good fashioned  in addition to preclinical human studies   validate that manipulation of GM evokes  immunomodulatory  actions in the tumor microenvironment(TME)  as well as antitumor reactions. Getting  insight in the crucial part  possessed by GM might aid in inventing innovative   approaches  both from  diagnostic  in addition to avoidance of MASH in addition to  its propagation to HCC . Thereby innovative research is needed to target  MASH stimulated HCC. Sequencing of genes along with  machine learning dependent evaluation  of outcomes would aid in isolation of crucial biomarker for the  estimation of liver diseases specifically in MASH correlated HCC. In such events greater quantities  of laboratory dependent mechanistic modes asssessment as well as clinical trials   in  considerable details are the requirements for determination  of constitution of GM ,which would aid in selecting correct bacterial strains of utility  for therapy of cancer. Thereby greater   corroboration  is required  with regards to translation of such present information  associated with working role  of gut   microbiome into diagnostic, prognostic as well as   therapeutic approaches in cases  afflicted  by HCC. Nevertheless,  it is validated  that GM manipulation  has given us a   direction for attractive therapeutic approaches for therapy in addition to avoidance of MASH along with  MASH correlated HCC recently Papadopoulos  et al. [111], detailed how  T cell-mediated adaptive immunity is implicated in the  transition from MASH to HCC. Earlier work concentrated  on innate immune system  alterations  nevertheless they  displayed significance  of adaptive immunity with MASH serving as niche for cancer  development,thus greater work is  needed to un ravel such association and  how GMinfluences it .

References

1. RinninellaE,RP,C M, FranceschiF,M GA,G A, etal .What is the healthy gut microbiota composition?a changing ecosystem  across age, environment,diet and  diseases. Microorganisms 2019; 7(1): 14.

2. DeVosWM, T H,V HM, Cani PD. Gut Microbiome and health mechanistic insight. Gut 2022;71(5):1020-32. 

3. KhanAA,S AT, SinghH,C P. Microbiota and cancer: current understanding    and mechanistic implications. Clin Transl Oncol 2022;24(2):193-202.  

4. Kulvinder Kochar Kaur,Allahbadia GN,Singh M. ’Are we any close to unraveling the mechanism of interactions among susceptibility genes towards Type 1 Diabetes,Gut Microbiota Along with Environmental factors ,specifically early diet patterns –A Systematic Review’’.  Endocrinology and Surgical Endocrinology, 2021; 2(1); DOI: http;//doi.org/03.2021/1.1005.

5. Kulvinder Kochar Kaur,Allahbadia GN,Singh M. Mode of Actions of Bile Acids in Avoidance of Colorectal Cancer Development and Therapeutic Applications in Treatment of Cancers--A Narrative Review’’. J Pharm Nutr Sci 2022; 12.

6. YangC,XuJ, XuX, XuW,TongB, WangS, etal . characteristics of gut microbiota in patients with metabolic associated fatty liver disease.   Sci Rep  2023;13(1):9988.

7. HuangF,LyuB,XieF,LiF,XingY,HanZ, etal.  From gut to liver: unvelling the  differences of Intestinal microbiota inNAFL and NASH patients. Front Microbiol 2024; 4(15):136744.

8. ThursbyE,JugeN. Introduction to  the human gut microbiota . Biochem J   2017;474(11): 1823-36.

9. Arumugam M,Raes J,Pelletier E,LePaslierD,YT,Mende DR, etal.  Enterotypes of the human gutmicrobiome. Nature 2011;473(7346):174-80. 

10. Ponziani FR, NicolettiA,Gasbarr ini A,PompiliM. Diagnostic and therapeutic of gut microbiota in patients with early Hepatocellular carcinoma. Ther Adv Med Oncol 2019;11:17588359848184. 

11. CholankerilG,Patel R,,Khurana S,Satapathy SK. Hepatocellular carcinoma in non alcoholic steatohepatitis:current  knowledge and implications for management. World JHepatol 2017; 9:-533-43.

12. SobhonsliduskA, ChanprasertyothinS, PongrujikornT,Kaewduang P,P K, P S, etal. The association of gut microbiota with non alcoholic steatohepatitis in Thais.  Bio Med Res Int 2018; 2018:16.

13. Chalasani N, Younossi ZM, Lavine AE,Charlton M, Cusi K, RinellaM, etal .The diagnosis and management of   non alcoholic fatty liver disease: practice guidance from the  American  Association for thestudy of   Liver disease.  Hepatology  2018;67: 328-57.

14. NairB,Kamath AJ,Tergaonkar V,S G,Sethi G,Nath LR.Mast  cells and the gut-  liver axis: implications for liver disease progression and therapy.Life Sci     2018;207:127-137.

15. Yu J,Marsh S,HuJ, FengW, WuC. The pathogenesis of non alcoholic fatty liver disease: interplay between diet, gut microbiota and genetic background.     2016;2016(1):2862173.

16. AlbillosA,DeGottardiA,RescignoM. The gut-  liver axis in liver disease: pathophysiological basis for therapy. J Hepatol  2020;72(3):558-77.

17. GuptaH,YounGS,Shin MJ,SukKT. Role of gut microbiota in  Hepatocarcinogenesis. Microorganisms 2019; 7(5): 121.

18. OhtaniN,Hara E. Gut-  liver axis mediated mechanism of liver cancer:a special focus on the role of gut microbiota. Cancer Sci 2021; 112(11): 4433-43.

19. LooTM,Kanda F, Watanabe Y, Yoshmoto S,K H,Arai Y, etal. Gut microbiota   promote obesity associated liver cancer through PGE2 mediated suppression of   antitumor   immunity gut microbiota  promotes obesity linked HCC  via immune escape.    Cancer  Discov  2017;7(5):522-38.

20. Kulvinder Kochar Kaur,Allahbadia GN,Singh M. Weight Loss Associated with High Protein Diet Intake in Obesity: Interactions of Gut Microbiota in ProteinSources Influencing this Positive Effect”. Acta Scientific Nutritional Health2018; 2 (7): 80-89